In this issue:
Using clinical/pathological data + genomic data to predict recurrence
Palbociclib + letrozole: patientreported QOL
Targeting CD73 expression looks promising in TNBC
A new immunotherapy approach successful in metastatic disease?
Intrathecal trastuzumab for breast cancer with carcinomatous meningitis
Tailored FEC vs standard BSA-based calculation
TNBC managed through two centres in Western Sydney
Survival after neoadjuvant trastuzumab or lapatinib in HER2+ disease
Employment participation after treatment of early-stage disease
Glucocorticoid receptor steroid sulfatase impacts on clinical outcomes
Please login below to download this issue (PDF)